POB2 COST-EFFECTIVENESS OF TREATING CARDIOMETABOLIC PATIENTS WITH RIMONABANT (ACOMPLIA®) IN A DANISH SETTING
Abstract
Authors
MS Knudsen PB Poulsen N Serup-Hansen
MS Knudsen PB Poulsen N Serup-Hansen
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now